Enzene Biosciences, a global biotech company based in Pune, will open its state-of-the-art biopharmaceutical manufacturing plant on the Princeton West Innovation Campus in Hopewell. Operations in the new facility, the company’s first location outside of India, are expected to begin in June 2024.
As a Contract Development and Manufacturing Organization (CDMO), Enzene Biosciences, a subsidiary of Alkem Laboratories, provides services to global pharmaceutical companies, partnering with them in their drug development and manufacturing processes. As part of Enzene’s expansion plans, the company will initially hire 50 employees and grow to 300 employees at its New Jersey facility.
Indian companies are increasingly establishing a strong presence in New Jersey by capitalising on the state’s favorable business environment. New Jersey has long been acknowledged as a national leader in life sciences, and Enzene’s expansion is yet another example of Indian companies finding their footing in the state.
Enzene’s local manufacturing capabilities will provide North American biopharmaceutical companies with streamlined supply chains, fast turnaround times, enhanced communication, and greater control over the manufacturing process. By providing comprehensive manufacturing capabilities under one roof, Enzene is well-positioned to support the development and production of a diverse range of biologics, contributing to the advancement of global healthcare and positively impacting patients’ lives worldwide.
